Gacyclidine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGacyclidine
Drug Alias Namegaciclidina加环利定Gacyclidine intratympanic controlled-releasegacyclidinumOTO-313 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsTinnitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIpsen Inc
China Registration ClassN/A

Develop Information

Active CompaniesOtonomy Inc
Inactive CompaniesNeurosystec Co
Active IndicationsTinnitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia